Patents by Inventor Rashmi Hedge

Rashmi Hedge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Administration of DKK1 muteins to treat fibrosis
    Patent number: 9751923
    Abstract: The present disclosure provides molecules, compositions and methods for treating scarring in organs. The molecules, compositions and methods treat scarring by modulating the WNT, platelet-derived growth factor receptor (PDGFR), transforming growth factor-beta (TGF3) and/or connective-tissue growth factor (CTGF) signaling pathways.
    Type: Grant
    Filed: November 1, 2013
    Date of Patent: September 5, 2017
    Assignee: University of Washington Through Its Center For Commercialization
    Inventors: Jeremy Duffield, Shuyu Ren, Rashmi Hedge
  • Molecules, Compositions and Methods to Treat Organ Scarring
    Publication number: 20150337021
    Abstract: The present disclosure provides molecules, compositions and methods for treating scarring in organs. The molecules, compositions and methods treat scarring by modulating the WNT, platelet-derived growth factor receptor (PDGFR), transforming growth factor-beta (TGF3) and/or connective-tissue growth factor (CTGF) signaling pathways.
    Type: Application
    Filed: November 1, 2013
    Publication date: November 26, 2015
    Inventors: Jeremy Duffield, Shuyu Ren, Rashmi Hedge